The level of BDNF in the acute period of ischemic stroke can be considered as a potential biomarker for the recovery of not only motor but also cognitive functions, as well as contribute to the search for additional targeted therapy in the course of stroke prevention. This evidence concerns the gene BDNF and ischemic stroke.